PDB Short entry for 1P4V HEADER HYDROLASE 24-APR-03 1P4V TITLE CRYSTAL STRUCTURE OF THE GLYCOSYLASPARAGINASE PRECURSOR D151N MUTANT TITLE 2 WITH GLYCINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: N(4)-(BETA-N-ACETYLGLUCOSAMINYL)-L-ASPARAGINASE PRECURSOR; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: GLYCOSYLASPARAGINASE, ALPHA AND BETA CHAINS; COMPND 5 SYNONYM: GLYCOSYLASPARAGINASE, ASPARTYLGLUCOSAMINIDASE, N4-N- ACETYL- COMPND 6 BETA-GLUCOSAMINYL, -L-ASPARAGINE AMIDASE, AGA; COMPND 7 EC: 3.5.1.26; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ELIZABETHKINGIA MENINGOSEPTICA; SOURCE 3 ORGANISM_TAXID: 238; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PMAL-C2X KEYWDS ALPHA BETA, BETA ALPHA, SANDWICH, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR X.QIAN,C.GUAN,H.C.GUO REVDAT 5 14-FEB-24 1P4V 1 REMARK REVDAT 4 27-OCT-21 1P4V 1 REMARK SEQADV REVDAT 3 24-FEB-09 1P4V 1 VERSN REVDAT 2 25-JAN-05 1P4V 1 JRNL REVDAT 1 06-MAY-03 1P4V 0 JRNL AUTH X.QIAN,C.GUAN,H.C.GUO JRNL TITL A DUAL ROLE FOR AN ASPARTIC ACID IN GLYCOSYLASPARAGINASE JRNL TITL 2 AUTOPROTEOLYSIS. JRNL REF STRUCTURE V. 11 997 2003 JRNL REFN ISSN 0969-2126 JRNL PMID 12906830 JRNL DOI 10.1016/S0969-2126(03)00150-3 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 41025 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4080 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4510 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 212 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1P4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-APR-03. REMARK 100 THE DEPOSITION ID IS D_1000019009. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1001 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43152 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.08000 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 3300, 0.1M TRIS, PH 7.5, 0.2M REMARK 280 LITHIUM SULFATE, 0.1% SODIUM AZIDE, 0.05M GLYCINE, EVAPORATION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 119 CG CD CE NZ REMARK 480 LYS A 130 CE NZ REMARK 480 LYS A 142 CG CD CE NZ REMARK 480 ILE A 147 CG1 CG2 CD1 REMARK 480 GLU A 148 CG CD OE1 OE2 REMARK 480 LYS A 283 CD CE NZ REMARK 480 LYS C 419 CD CE NZ REMARK 480 LYS C 430 CD CE NZ REMARK 480 GLU C 448 CD OE1 OE2 REMARK 480 LYS C 563 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH C 201 O HOH C 211 0.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 11 174.27 62.73 REMARK 500 ASN A 87 72.77 -115.48 REMARK 500 LYS A 142 77.54 -153.15 REMARK 500 ALA A 189 -85.52 -101.51 REMARK 500 ILE A 197 -63.24 -122.48 REMARK 500 ASP A 281 -159.53 -145.60 REMARK 500 LEU A 294 95.45 -68.13 REMARK 500 TRP C 311 171.42 66.79 REMARK 500 ASP C 371 -163.97 -100.03 REMARK 500 ASN C 387 75.43 -119.80 REMARK 500 ALA C 489 -84.87 -101.58 REMARK 500 ILE C 497 -64.70 -132.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLY A 296 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLY C 596 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1P4K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GLYCOSYLASPARAGINASE PRECURSOR D151N MUTANT DBREF 1P4V A 1 295 UNP Q47898 ASPG_FLAME 46 340 DBREF 1P4V C 301 595 UNP Q47898 ASPG_FLAME 46 340 SEQADV 1P4V ASN A 151 UNP Q47898 ASP 196 ENGINEERED MUTATION SEQADV 1P4V ASN C 451 UNP Q47898 ASP 196 ENGINEERED MUTATION SEQRES 1 A 295 THR THR ASN LYS PRO ILE VAL LEU SER THR TRP ASN PHE SEQRES 2 A 295 GLY LEU HIS ALA ASN VAL GLU ALA TRP LYS VAL LEU SER SEQRES 3 A 295 LYS GLY GLY LYS ALA LEU ASP ALA VAL GLU LYS GLY VAL SEQRES 4 A 295 ARG LEU VAL GLU ASP ASP PRO THR GLU ARG SER VAL GLY SEQRES 5 A 295 TYR GLY GLY ARG PRO ASP ARG ASP GLY ARG VAL THR LEU SEQRES 6 A 295 ASP ALA CYS ILE MET ASP GLU ASN TYR ASN ILE GLY SER SEQRES 7 A 295 VAL ALA CYS MET GLU HIS ILE LYS ASN PRO ILE SER VAL SEQRES 8 A 295 ALA ARG ALA VAL MET GLU LYS THR PRO HIS VAL MET LEU SEQRES 9 A 295 VAL GLY ASP GLY ALA LEU GLU PHE ALA LEU SER GLN GLY SEQRES 10 A 295 PHE LYS LYS GLU ASN LEU LEU THR ALA GLU SER GLU LYS SEQRES 11 A 295 GLU TRP LYS GLU TRP LEU LYS THR SER GLN TYR LYS PRO SEQRES 12 A 295 ILE VAL ASN ILE GLU ASN HIS ASN THR ILE GLY MET ILE SEQRES 13 A 295 ALA LEU ASP ALA GLN GLY ASN LEU SER GLY ALA CYS THR SEQRES 14 A 295 THR SER GLY MET ALA TYR LYS MET HIS GLY ARG VAL GLY SEQRES 15 A 295 ASP SER PRO ILE ILE GLY ALA GLY LEU PHE VAL ASP ASN SEQRES 16 A 295 GLU ILE GLY ALA ALA THR ALA THR GLY HIS GLY GLU GLU SEQRES 17 A 295 VAL ILE ARG THR VAL GLY THR HIS LEU VAL VAL GLU LEU SEQRES 18 A 295 MET ASN GLN GLY ARG THR PRO GLN GLN ALA CYS LYS GLU SEQRES 19 A 295 ALA VAL GLU ARG ILE VAL LYS ILE VAL ASN ARG ARG GLY SEQRES 20 A 295 LYS ASN LEU LYS ASP ILE GLN VAL GLY PHE ILE ALA LEU SEQRES 21 A 295 ASN LYS LYS GLY GLU TYR GLY ALA TYR CYS ILE GLN ASP SEQRES 22 A 295 GLY PHE ASN PHE ALA VAL HIS ASP GLN LYS GLY ASN ARG SEQRES 23 A 295 LEU GLU THR PRO GLY PHE ALA LEU LYS SEQRES 1 C 295 THR THR ASN LYS PRO ILE VAL LEU SER THR TRP ASN PHE SEQRES 2 C 295 GLY LEU HIS ALA ASN VAL GLU ALA TRP LYS VAL LEU SER SEQRES 3 C 295 LYS GLY GLY LYS ALA LEU ASP ALA VAL GLU LYS GLY VAL SEQRES 4 C 295 ARG LEU VAL GLU ASP ASP PRO THR GLU ARG SER VAL GLY SEQRES 5 C 295 TYR GLY GLY ARG PRO ASP ARG ASP GLY ARG VAL THR LEU SEQRES 6 C 295 ASP ALA CYS ILE MET ASP GLU ASN TYR ASN ILE GLY SER SEQRES 7 C 295 VAL ALA CYS MET GLU HIS ILE LYS ASN PRO ILE SER VAL SEQRES 8 C 295 ALA ARG ALA VAL MET GLU LYS THR PRO HIS VAL MET LEU SEQRES 9 C 295 VAL GLY ASP GLY ALA LEU GLU PHE ALA LEU SER GLN GLY SEQRES 10 C 295 PHE LYS LYS GLU ASN LEU LEU THR ALA GLU SER GLU LYS SEQRES 11 C 295 GLU TRP LYS GLU TRP LEU LYS THR SER GLN TYR LYS PRO SEQRES 12 C 295 ILE VAL ASN ILE GLU ASN HIS ASN THR ILE GLY MET ILE SEQRES 13 C 295 ALA LEU ASP ALA GLN GLY ASN LEU SER GLY ALA CYS THR SEQRES 14 C 295 THR SER GLY MET ALA TYR LYS MET HIS GLY ARG VAL GLY SEQRES 15 C 295 ASP SER PRO ILE ILE GLY ALA GLY LEU PHE VAL ASP ASN SEQRES 16 C 295 GLU ILE GLY ALA ALA THR ALA THR GLY HIS GLY GLU GLU SEQRES 17 C 295 VAL ILE ARG THR VAL GLY THR HIS LEU VAL VAL GLU LEU SEQRES 18 C 295 MET ASN GLN GLY ARG THR PRO GLN GLN ALA CYS LYS GLU SEQRES 19 C 295 ALA VAL GLU ARG ILE VAL LYS ILE VAL ASN ARG ARG GLY SEQRES 20 C 295 LYS ASN LEU LYS ASP ILE GLN VAL GLY PHE ILE ALA LEU SEQRES 21 C 295 ASN LYS LYS GLY GLU TYR GLY ALA TYR CYS ILE GLN ASP SEQRES 22 C 295 GLY PHE ASN PHE ALA VAL HIS ASP GLN LYS GLY ASN ARG SEQRES 23 C 295 LEU GLU THR PRO GLY PHE ALA LEU LYS HET GLY A 296 5 HET GLY C 596 5 HETNAM GLY GLYCINE FORMUL 3 GLY 2(C2 H5 N O2) FORMUL 5 HOH *212(H2 O) HELIX 1 1 PHE A 13 SER A 26 1 14 HELIX 2 2 LYS A 30 ASP A 45 1 16 HELIX 3 3 ASN A 87 THR A 99 1 13 HELIX 4 4 GLY A 106 GLN A 116 1 11 HELIX 5 5 THR A 125 LYS A 137 1 13 HELIX 6 6 HIS A 205 VAL A 213 1 9 HELIX 7 7 VAL A 213 GLN A 224 1 12 HELIX 8 8 THR A 227 ARG A 246 1 20 HELIX 9 9 ASN A 249 ILE A 253 5 5 HELIX 10 10 PHE C 313 SER C 326 1 14 HELIX 11 11 LYS C 330 ASP C 345 1 16 HELIX 12 12 ASN C 387 THR C 399 1 13 HELIX 13 13 GLY C 406 GLN C 416 1 11 HELIX 14 14 THR C 425 LYS C 437 1 13 HELIX 15 15 HIS C 505 VAL C 513 1 9 HELIX 16 16 VAL C 513 GLN C 524 1 12 HELIX 17 17 THR C 527 ARG C 546 1 20 HELIX 18 18 ASN C 549 ILE C 553 5 5 SHEET 1 A 8 MET A 103 VAL A 105 0 SHEET 2 A 8 ILE A 76 MET A 82 1 N SER A 78 O LEU A 104 SHEET 3 A 8 LEU A 65 MET A 70 -1 N ALA A 67 O VAL A 79 SHEET 4 A 8 LEU A 164 THR A 170 -1 O THR A 170 N ASP A 66 SHEET 5 A 8 ILE A 153 LEU A 158 -1 N MET A 155 O ALA A 167 SHEET 6 A 8 ILE A 6 THR A 10 -1 N LEU A 8 O ILE A 156 SHEET 7 A 8 PHE A 277 ASP A 281 -1 O ALA A 278 N SER A 9 SHEET 8 A 8 GLY A 284 GLU A 288 -1 O GLU A 288 N PHE A 277 SHEET 1 B 5 LEU A 191 ASP A 194 0 SHEET 2 B 5 GLY A 198 GLY A 204 -1 O GLY A 198 N ASP A 194 SHEET 3 B 5 VAL A 255 ASN A 261 -1 O LEU A 260 N ALA A 199 SHEET 4 B 5 TYR A 266 CYS A 270 -1 O GLY A 267 N ALA A 259 SHEET 5 B 5 GLY A 291 PHE A 292 1 O GLY A 291 N CYS A 270 SHEET 1 C 8 MET C 403 VAL C 405 0 SHEET 2 C 8 ILE C 376 MET C 382 1 N SER C 378 O LEU C 404 SHEET 3 C 8 LEU C 365 MET C 370 -1 N LEU C 365 O MET C 382 SHEET 4 C 8 LEU C 464 THR C 470 -1 O GLY C 466 N MET C 370 SHEET 5 C 8 ILE C 453 LEU C 458 -1 N MET C 455 O ALA C 467 SHEET 6 C 8 ILE C 306 THR C 310 -1 N LEU C 308 O ILE C 456 SHEET 7 C 8 PHE C 577 ASP C 581 -1 O HIS C 580 N VAL C 307 SHEET 8 C 8 GLY C 584 GLU C 588 -1 O GLU C 588 N PHE C 577 SHEET 1 D 5 LEU C 491 ASP C 494 0 SHEET 2 D 5 GLY C 498 GLY C 504 -1 O GLY C 498 N ASP C 494 SHEET 3 D 5 VAL C 555 ASN C 561 -1 O LEU C 560 N ALA C 499 SHEET 4 D 5 TYR C 566 CYS C 570 -1 O GLY C 567 N ALA C 559 SHEET 5 D 5 GLY C 591 PHE C 592 1 O GLY C 591 N CYS C 570 CISPEP 1 LYS A 4 PRO A 5 0 0.58 CISPEP 2 LYS C 304 PRO C 305 0 -0.04 SITE 1 AC1 9 THR A 152 GLY A 172 MET A 173 ARG A 180 SITE 2 AC1 9 ASP A 183 SER A 184 GLY A 204 GLY A 206 SITE 3 AC1 9 HOH A 301 SITE 1 AC2 10 HOH C 7 HOH C 10 THR C 452 GLY C 472 SITE 2 AC2 10 MET C 473 ARG C 480 ASP C 483 SER C 484 SITE 3 AC2 10 GLY C 504 GLY C 506 CRYST1 45.877 52.369 61.741 80.92 90.41 105.10 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021797 0.005881 -0.000805 0.00000 SCALE2 0.000000 0.019778 -0.003237 0.00000 SCALE3 0.000000 0.000000 0.016413 0.00000